Centiva Capital’s Biotech Acquisition Company Warrant BIOTW Stock Holding History

Centiva Capital’s Portfolio BIOTW Stock Details BIOTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,483	Closed	-$989	–	2034
2022 Q4	$989	Hold	16,483	–	–	﹤0.01%	1319
2022 Q3	$1K	Hold	16,483	–	–	﹤0.01%	1437
2022 Q2	$1K	Buy	+16,483	New	+$3.4K	﹤0.01%	1637

Centiva Capital's BIOTW Position: Q1 2023 in Review

Centiva Capital sold out of Biotech Acquisition Company Warrant (BIOTW) in Q1 2023, closing a stake of 16,483 shares — an estimated $989 sold.

Centiva Capital first reported a position in BIOTW in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 0 funds tracked by Wall St. Rank hold BIOTW as of Q1 2023.

Centiva Capital reported no remaining Biotech Acquisition Company Warrant position as of Q1 2023 after selling out during the quarter.
Centiva Capital sold 16,483 Biotech Acquisition Company Warrant shares in Q1 2023, an estimated $989.
Centiva Capital first reported a position in Biotech Acquisition Company Warrant in Q2 2022 and held it in 3 quarters.
Centiva Capital's Biotech Acquisition Company Warrant position peaked at $1K in Q3 2022.
0 funds tracked by Wall St. Rank held Biotech Acquisition Company Warrant as of Q1 2023.

Based on Centiva Capital's 13F filing for Q1 2023, filed 15 May 2023.